Last reviewed: July 2, 2026
Last updated: July 2, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Zepbound (semaglutide) has become a popular weight loss medication, but pregnancy planning creates important medical questions. The FDA recommends stopping semaglutide at least two months before attempting conception, as animal studies show potential effects on fetal development. Understanding these guidelines helps you make informed decisions about your fertility timeline.
Zepbound Safety Profile During Conception Planning
Zepbound contains semaglutide, a GLP-1 receptor agonist that delays gastric emptying and reduces appetite. Clinical trials in animals showed potential risks to developing fetuses, prompting the FDA to recommend a two-month washout period before conception attempts. This conservative approach reflects standard pharmaceutical caution when pregnancy risk exists, though human pregnancy data remains limited because pregnant individuals are excluded from most drug trials.
Weight loss medications affect more than appetite—they influence blood sugar regulation, insulin sensitivity, and metabolic hormones that play roles in reproductive health. Some evidence suggests significant weight loss itself can improve fertility outcomes in people with obesity, but the mechanism and timing of medication cessation matter for safety. Your reproductive endocrinologist and weight management provider should coordinate care to balance fertility goals with metabolic health.
Timeline Considerations: When to Stop Semaglutide Before Trying to Conceive
The recommended two-month discontinuation window aligns with semaglutide's gradual elimination from your system. After stopping weekly injections, the medication clears slowly over four to six weeks, with metabolic effects persisting longer. Starting this timeline before your actual conception attempts gives your hormonal system time to reset and ensures medication exposure is minimized during early pregnancy when organ development occurs.
Many fertility specialists suggest discussing medication timing during preconception counseling, ideally three to four months before attempting pregnancy. This allows time to stabilize your weight after stopping medication, assess whether weight regain occurs, and potentially explore alternative approaches if needed. PlexusDx can help you plan this transition with personalized guidance based on your metabolic genetics and weight management history.
Compounded Tirzepatide as a Preconception Weight Management Option
If you need continued weight loss support before your two-month semaglutide washout begins, compounded tirzepatide injection from PlexusDx offers a potential alternative pathway. While tirzepatide (Mounjaro's active ingredient) also carries pregnancy precautions similar to semaglutide, it provides options for medication management during your preconception planning phase. Compounded tirzepatide from licensed 503A pharmacies starts at $249 per month with no flat per-compound pricing increases—your dose may need to go up, but your price won't.
The choice between continuing semaglutide or transitioning to another GLP-1 medication depends on your individual fertility timeline and weight loss goals. Some patients benefit from the behavioral changes and metabolic improvements achieved during medication use, even if they discontinue before conception. PlexusDx's Precision Peptide Genetic Test ($99 add-on after first month) analyzes genetic variants affecting GLP-1 receptor function and metabolic pathways, helping identify whether GLP-1 therapy aligns with your genetic predispositions for sustained weight management.
Medical Coordination and Personalized Conception Planning
Fertility planning with weight loss medications requires collaboration between your OB-GYN, reproductive endocrinologist, and weight management team. PlexusDx provides support through personalized medication options accessible in all 50 states without insurance requirements—HSA and FSA accounts cover eligible compounds. Your provider can review PlexusDx's compounded options and genetic insights to build a conception-safe weight management plan tailored to your timeline and health profile.
Pregnancy planning after significant weight loss may improve fertility outcomes by reducing inflammation, improving insulin sensitivity, and normalizing reproductive hormone levels. The transition period off GLP-1 medications offers an opportunity to establish sustainable lifestyle habits before conception. PlexusDx coordinates with your fertility team to ensure medication decisions align with conception goals, timing, and your unique metabolic genetics.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I take Zepbound while actively trying to get pregnant?
No. The FDA recommends stopping semaglutide at least two months before attempting conception due to potential fetal risks observed in animal studies. This washout period allows the medication to clear your system before pregnancy occurs. Discuss your specific timeline with your OB-GYN and fertility specialist to coordinate when to discontinue and plan your conception attempts.
What happens if I become pregnant while taking Zepbound?
Contact your healthcare provider immediately if you become pregnant while on semaglutide. Early pregnancy involves rapid fetal organ development, and stopping the medication right away minimizes exposure during this critical window. Most providers recommend immediate discontinuation and close monitoring through your first trimester to ensure fetal health.
How long does semaglutide stay in your system after stopping?
Semaglutide clears gradually over four to six weeks after your last injection, though metabolic effects may persist slightly longer. The two-month FDA recommendation provides a safety buffer beyond complete clearance to ensure minimal medication exposure during early pregnancy. Individual factors like kidney and liver function affect clearance rates, so discuss your specific timeline with your healthcare provider.
Does stopping Zepbound affect fertility or conception rates?
Stopping semaglutide itself doesn't directly harm fertility. The weight loss achieved during treatment may actually improve fertility outcomes by reducing inflammation and normalizing reproductive hormones. However, rapid weight regain after stopping medication can reverse fertility benefits, making it important to maintain the lifestyle changes developed during treatment.
What does PlexusDx offer for preconception weight management?
PlexusDx provides compounded GLP-1 medications from licensed 503A pharmacies, including tirzepatide injection ($249/month) and other options, all accessible nationwide without insurance. The Precision Peptide Genetic Test ($99 add-on) analyzes 14 metabolic pathways and 150+ genetic insights to personalize your weight management approach. Compounded options give flexibility as you plan your conception timeline with medical coordination.
Is compounded semaglutide from PlexusDx safer than brand Zepbound during conception planning?
Compounded semaglutide and brand Zepbound contain the same active medication and carry identical pregnancy precautions—both require a two-month washout before conception. PlexusDx sources from licensed 503A compounding pharmacies and offers personalized dosing options, but safety timing for pregnancy planning remains the same across all semaglutide products.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Ozempic and Meal Timing: What You Need to Know for Your Weight Loss Journey
How Quick is Weight Loss with Wegovy?